Here's some science trivia for you: unlike the inner retina in most animals (including us), birds' inner retinas function ...

LifeScan CEO Valerie Asbury said on social media today that she is retiring from the glucose management technology developer.

Letitia explains how a small medical device, designed to help manage the illness, is now blamed for sending hundreds of ...

Ozempic isn’t the only drug that mimics the natural GLP-1 hormone, so users feel fuller for longer and eat less. There’s also Zepbound, Mounjaro, Trulicity and Victoza — and many more on the horizon ...

Glucotrack (Nasdaq:GCTK) announced today that it received new U.S. patents for its continuous blood glucose monitoring (CBGM) ...

Glucotrack, Inc. (Nasdaq: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is currently developing a long-term implantable ...

A simple smart speaker may be the latest tool to help seniors with some of the mental and physical challenges of type 2 diabetes. A new study published in JAMA Network Open reports that using an ...

The study explains the mechanism behind up to 100× sensitivity amplification in glucose sensorsThe article was published in Biosensors and ...

When wheat is processed to make white flour, the bran—the high fiber portion—is removed. This makes white bread more quickly digested in the body, and it can cause a faster and higher spike in blood ...

Alexander Zverev booked a third straight Australian Open semifinal on Tuesday, outlasting Learner Tien 6-3, 6-7(5), 6-1, ...

A 58-year-old woman was admitted to the hospital 3 weeks after lumbar surgery because of diplopia and fever. Left leg pain and a rash had preceded the fever and diplopia. A diagnosis was made.

MASLD is now being recognized as a major public health concern with long-term consequences if left undetected.